4/3
09:15 am
lrmr
Rating for LRMR
Low
Report
Rating for LRMR
4/3
08:02 am
lrmr
Larimar Therapeutics initiated with bullish view at Leerink
Low
Report
Larimar Therapeutics initiated with bullish view at Leerink
3/18
02:59 pm
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $25.00 price target on the stock.
Medium
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $25.00 price target on the stock.
3/18
02:59 pm
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $25.00 price target on the stock.
Medium
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $25.00 price target on the stock.
3/15
10:35 am
lrmr
Rating for LRMR
Low
Report
Rating for LRMR
3/15
10:35 am
lrmr
Rating for LRMR
Low
Report
Rating for LRMR
3/12
10:06 am
lrmr
Rating for LRMR
Low
Report
Rating for LRMR
3/12
10:06 am
lrmr
Rating for LRMR
Low
Report
Rating for LRMR
2/13
10:39 am
lrmr
Rating for LRMR
High
Report
Rating for LRMR
2/13
10:39 am
lrmr
Rating for LRMR
High
Report
Rating for LRMR
2/13
09:15 am
lrmr
Rating for LRMR
Medium
Report
Rating for LRMR
2/13
09:15 am
lrmr
Rating for LRMR
Medium
Report
Rating for LRMR